Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.
King B, Ohyama M, Senna M, Shapiro J, Dutronc Y, Durand F, Liu C, Yu G, Kolodsick J, Chiasserini C, Somani N, Piraccini BM. King B, et al. Among authors: ohyama m. J Am Acad Dermatol. 2025 Feb;92(2):299-306. doi: 10.1016/j.jaad.2024.09.072. Epub 2024 Oct 22. J Am Acad Dermatol. 2025. PMID: 39447758 Clinical Trial.
Long-term outcomes of intravenous corticosteroid pulse therapy for rapidly progressive alopecia areata: A single-center retrospective analysis of 106 cases and usefulness evaluation of a scoring system originally designed for half-year efficacy prediction for extended periods.
Fukuyama M, Kinoshita-Ise M, Ohyama M. Fukuyama M, et al. Among authors: ohyama m. J Dermatol. 2025 Jan;52(1):112-121. doi: 10.1111/1346-8138.17506. Epub 2024 Oct 14. J Dermatol. 2025. PMID: 39400425
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies.
Mostaghimi A, Ko J, Tosti A, McMichael A, Ohyama M, Ito T, Dutronc Y, Ball S, Yu G, Murage M, Chen YF, Chiasserini C, Wollenberg A. Mostaghimi A, et al. Among authors: ohyama m. J Am Acad Dermatol. 2024 Oct;91(4):729-732. doi: 10.1016/j.jaad.2024.05.077. Epub 2024 Jun 7. J Am Acad Dermatol. 2024. PMID: 38852742 Free article. No abstract available.
Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan.
Kojima M, Mieno H, Ueta M, Nakata M, Teramukai S, Sunaga Y, Ochiai H, Iijima M, Kokaze A, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Ikezawa Z, Mizukawa Y, Ohyama M, Shiohara T, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Hashimoto K, Takahashi H, Niihara H, Morita E, Sueki H, Kinoshita S, Sotozono C. Kojima M, et al. Among authors: ohyama m. Am J Ophthalmol. 2024 Nov;267:50-60. doi: 10.1016/j.ajo.2024.05.011. Epub 2024 May 24. Am J Ophthalmol. 2024. PMID: 38795750 Free article.
425 results